Healthcare providers should use caution when considering the treatment of COVID-19 patients with hydroxychloroquine and azithromycin if the patients have cardiovascular disease.

U.S. hospitals are facing numerous challenges as they work to combat the continued spread of COVID-19, according to a new government survey of more than 300 hospital administrators.

A new international research study will focus on treatment strategies and outcomes of ST-segment elevation myocardial infarction (STEMI) patients with known or suspected COVID-19.

As COVID-19 continues to keep healthcare providers busy, fewer patients appear to be seeking care for other serious issues, including cardiovascular complications such as heart attack and stroke.

Though the new coronavirus is often associated with older patients and those with preexisting conditions, it has been diagnosed in young children as well.

The Duke Clinical Research Institute (DCRI) has launched a new study aimed at evaluating how COVID-19 is impacting the health of physicians throughout the United States. Researchers will also assess the potential ability of hydroxychloroquine to limit infections among high-risk healthcare providers.

What, exactly, do patients need to know about the relationship between hypertension and COVID-19?

The COVID-19 pandemic is changing patient care at hospitals all over the world, but a group of leading surgeons wants to make sure people aren’t ignoring stroke symptoms due to fears over getting the virus.